Pharmafile Logo

FDA Map

FDAMAP is a group of global healthcare experts that conducts highly informative conferences, workshops and other training sessions for pharma, diagnostics and medical device industry professionals. Our panels of speakers include experts in clinical trials, data management, statistics, regulatory affairs, safety reporting, pharmacovigilance, social media marketing of medical products (drugs, biologics and medical devices), project management, GMP, GCP GLP, FDA/EMA audits, and information technology. Learn more about our Training and Consultancy Programs (Regulatory Workshops, FDA Seminars and Conferences, and Regulatory Consultancy) on our website www.fdamap.com

We work with professionals, regulators, and government agencies to build unique platforms for consultation, training, networking, and professional development. We strive hard to make high quality, mutually beneficial relationships with our customers and partners alike.

The FDAMap initiative is the newest venture of a group of leading experts from the industry and government to bring professionals at all levels together to create best practices based on logic, logistics, legal, and least-burdensome compliance. Visit: www.fdamap.com

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

20203 Goshen Rd,, Suite 261 Gaithersburg, Gaithersburg, Maryland, MD 20879, United States
+1-410-501-5777

 Latest Content from PMHub 

It’s not just our logo that’s green

Press Releases | April 3, 2020 | Resonant Group

Origins Insights believe not only in the value of understanding how people interact with their health, but also the need to care for the wider world around us.

Today’s reality: how to make social distancing work in medcomms

At Lucid, we don’t just want to cope with COVID-19.The current situation certainly presents an unprecedented challenge to delivering medical education. The daily update of cancellations and postponements has become...

Mobile ethnography means no delays to the PoTS LIVE charity project

Press Releases | April 1, 2020 | Resonant Group

The team at Origins Insights are excited to introduce PoTS LIVE, our pro bono mobile ethnography project. Remarkably, the project marches on with its fieldwork phase even with the current...

Delivering true value: what does it mean for KAM in cancer care?

Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve

Remote Working: Join the Revolution Workshop

As a nation, we are still coming to terms with our ‘new normal’, where social distancing has forced us out of the office and into our homes. For some this...

Onyx Health strengthens its top team with senior appointment

Press Releases | March 31, 2020 | Onyx Health

Onyx Health have recently welcomed back Alex Gandhi as Account Director to strengthen their senior management team

The Pivot

In times of uncertainty it is critical for businesses to take action to protect their brand image and longevity.

Behaviour change – is there something missing?

Press Releases | March 30, 2020 | Resonant Group

Successful and impactful behaviour change requires commitment and time

COVID-19 message to clients from OPEN Health CEO, David Rowley

Press Releases | March 27, 2020 | OPEN Health

Dear OPEN Health Clients,I want to highlight to our clients what we’re doing in response to the Coronavirus outbreak to protect our staff, our clients and the community.We’re following the...

The Lucid Group Thirsty Thursday: What’s in a story?

Yes, it’s that time of the month, a time everyone at Lucid has come to love and anticipate. Whether it’s sharing best practice, learning about new skills, gathering insights or...